[go: up one dir, main page]

TNSN99133A1 - Procede perfectionne pour la preparation de bases de schiff et produits ainsi obtenus - Google Patents

Procede perfectionne pour la preparation de bases de schiff et produits ainsi obtenus

Info

Publication number
TNSN99133A1
TNSN99133A1 TNTNSN99133A TNSN99133A TNSN99133A1 TN SN99133 A1 TNSN99133 A1 TN SN99133A1 TN TNSN99133 A TNTNSN99133 A TN TNSN99133A TN SN99133 A TNSN99133 A TN SN99133A TN SN99133 A1 TNSN99133 A1 TN SN99133A1
Authority
TN
Tunisia
Prior art keywords
products
preparation
schiff bases
improved process
schiff
Prior art date
Application number
TNTNSN99133A
Other languages
English (en)
Inventor
Allan Hay Bruce
Thomas Clark Michael
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of TNSN99133A1 publication Critical patent/TNSN99133A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
    • C07K1/1072—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides by covalent attachment of residues or functional groups
    • C07K1/1077—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides by covalent attachment of residues or functional groups by covalent attachment of residues other than amino acids or peptide residues, e.g. sugars, polyols, fatty acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/61—Growth hormone [GH], i.e. somatotropin

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Endocrinology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Analytical Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)

Abstract

-L'INVENTION CONCERNE UN PROCEDE POUR LA PREPARATION DE PRODUITS FINALS D'ADDITION PAR CONDENSATION CONSISTANT EN BASES DE SCHIFF. LES CONSTITUANTS DE CES PRODUITS COMPRENNENT UNE PROTEINE A ACTIVITE BENEFIQUE CHEZ DES ANIMAUX ET UN O-HYDROXY-ALDEHYDE AROMATIQUE. ELLE CONCERNE EGALEMENT LES BASES DE SCHIFF AINSI OBTENUES. APPLICATION : UTILISATION DES PRODUITS OBTENUS POUR LE TRAITEMENT D'ANIMAUX ET DE L'HOMME.
TNTNSN99133A 1998-06-26 1999-06-23 Procede perfectionne pour la preparation de bases de schiff et produits ainsi obtenus TNSN99133A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US9071498P 1998-06-26 1998-06-26

Publications (1)

Publication Number Publication Date
TNSN99133A1 true TNSN99133A1 (fr) 2005-11-10

Family

ID=22223965

Family Applications (1)

Application Number Title Priority Date Filing Date
TNTNSN99133A TNSN99133A1 (fr) 1998-06-26 1999-06-23 Procede perfectionne pour la preparation de bases de schiff et produits ainsi obtenus

Country Status (23)

Country Link
US (1) US20030125528A1 (fr)
EP (1) EP1087989A1 (fr)
JP (1) JP2002519356A (fr)
KR (1) KR20010083070A (fr)
CN (1) CN1305490A (fr)
AP (1) AP9901593A0 (fr)
AU (1) AU3842499A (fr)
BR (1) BR9912203A (fr)
CA (1) CA2331388A1 (fr)
CZ (1) CZ20004806A3 (fr)
GT (1) GT199900097A (fr)
HU (1) HUP0102693A3 (fr)
ID (1) ID27131A (fr)
IL (1) IL139585A0 (fr)
MA (1) MA24885A1 (fr)
PA (1) PA8476501A1 (fr)
PL (1) PL345264A1 (fr)
RU (1) RU2201936C2 (fr)
TN (1) TNSN99133A1 (fr)
TR (1) TR200003732T2 (fr)
UY (1) UY25579A1 (fr)
WO (1) WO2000000507A1 (fr)
YU (1) YU78600A (fr)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001316294A (ja) 2000-03-14 2001-11-13 Pfizer Prod Inc ｏ−バニリンおよびｏ−バニリン／テトラメチルクロマニルカルボン酸化合物の組み合わせの使用法
US20050142217A1 (en) * 2000-04-26 2005-06-30 Adams Michael A. Formulations and methods of using nitric oxide mimetics against a malignant cell phenotype
US6432077B1 (en) * 2000-12-26 2002-08-13 Sensormedics Corporation Device and method for treatment of surface infections with nitric oxide
US20070219131A1 (en) * 2004-04-15 2007-09-20 Ben-Sasson Shmuel A Compositions capable of facilitating penetration across a biological barrier
MX2007004676A (es) 2004-10-27 2007-11-14 Univ Denver Analogos de la hormona adrenocorticotropica y metodos relacionados.
ITMO20060222A1 (it) * 2006-07-10 2008-01-11 Alfio Bertolini Pacchetto di medicazione antiemorragico
EP2155643B1 (fr) 2007-06-08 2016-08-10 MannKind Corporation Inhibiteurs d'ire-1a
CN101861142A (zh) * 2007-11-22 2010-10-13 诺沃-诺迪斯克保健股份有限公司 含醛化合物对液体配制因子VII(a)多肽的稳定化
PL2343982T3 (pl) 2008-09-17 2017-10-31 Chiasma Inc Kompozycje farmaceutyczne i związane z nimi sposoby dostarczania
DK2680696T3 (en) * 2010-12-03 2015-08-03 Dow Agrosciences Llc Methods for Preparing Enamines
CN104262600B (zh) * 2014-09-09 2016-01-06 天津大学 同一侧基上含有西弗碱和巯基的双重敏感型两亲性共聚物及其制备方法与应用
WO2016057754A1 (fr) * 2014-10-10 2016-04-14 The University Of Kansas Activité antibiotique de polymères séquestrant le fer
WO2016126830A1 (fr) 2015-02-03 2016-08-11 Chiasma Inc. Méthode de traitement de maladies
WO2017180714A1 (fr) * 2016-04-12 2017-10-19 University Of Kansas Activité antifongique de polymères séquestrant le fer
CN106008566A (zh) * 2016-06-27 2016-10-12 金子烁 5-氯水杨醛缩丙氨酸席夫碱锌配合物及其制备方法
RU2729391C2 (ru) * 2018-12-28 2020-08-06 Федеральное государственное бюджетное учреждение науки институт биоорганической химии им. академиков М.М. Шемякина и Ю.А. Овчинникова Российской академии наук (ИБХ РАН) Моноклональное антитело, способное нейтрализовать биологическую активность интерферона бета-1а человека
CN110332260B (zh) * 2019-08-12 2021-09-24 湖北康晨安宝矿业设备有限责任公司 一种前桥行驻一体制动器
CN112194574B (zh) * 2020-10-13 2022-03-29 天津大学 一种邻香草醛球形晶体的制备方法
US11141457B1 (en) 2020-12-28 2021-10-12 Amryt Endo, Inc. Oral octreotide therapy and contraceptive methods
CN113105359A (zh) * 2021-03-05 2021-07-13 天津大学 一种席夫碱化合物及其制备方法
CN115053909B (zh) * 2022-06-22 2024-04-19 湖南工业大学 一种生物基绿色复合抗菌剂及其制备方法和应用
CN116173314B (zh) * 2023-01-17 2024-04-16 成都美益博雅材料科技有限公司 复合材料及其制备方法和用途
US12235043B1 (en) * 2024-08-30 2025-02-25 ALI Pharmaceutical Manufacturing, LLC Desiccated thyroid extract manufacturing method

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8703718D0 (en) * 1987-02-18 1987-03-25 Dalgety Uk Ltd Colour production
DE68924783T2 (de) * 1988-09-30 1996-03-28 Neorx Corp Wässrige additivsysteme, verfahren und polymerteilchen.
US5198422A (en) * 1992-06-11 1993-03-30 Smithkline Beecham Corporation Stabilized somatotropin for parenteral administration

Also Published As

Publication number Publication date
CZ20004806A3 (cs) 2001-08-15
EP1087989A1 (fr) 2001-04-04
KR20010083070A (ko) 2001-08-31
JP2002519356A (ja) 2002-07-02
US20030125528A1 (en) 2003-07-03
PA8476501A1 (es) 2001-12-14
ID27131A (id) 2001-03-01
HUP0102693A2 (hu) 2001-11-28
AP9901593A0 (en) 1999-06-30
CA2331388A1 (fr) 2000-01-06
BR9912203A (pt) 2001-04-10
HUP0102693A3 (en) 2002-12-28
GT199900097A (es) 2000-12-15
WO2000000507A1 (fr) 2000-01-06
CN1305490A (zh) 2001-07-25
YU78600A (sh) 2002-11-15
RU2201936C2 (ru) 2003-04-10
MA24885A1 (fr) 1999-12-31
TR200003732T2 (tr) 2001-06-21
AU3842499A (en) 2000-01-17
IL139585A0 (en) 2002-02-10
UY25579A1 (es) 2000-02-23
PL345264A1 (en) 2001-12-03

Similar Documents

Publication Publication Date Title
TNSN99133A1 (fr) Procede perfectionne pour la preparation de bases de schiff et produits ainsi obtenus
TNSN98019A1 (fr) Derives d'acide arylsulfonylaminohydroxamique, procede pour leur preparation et compositions pharmaceutiques les contenant.
ATE500823T1 (de) Arzneimittel zur behandlung von hiv-infizierten säugetieren
EA200100524A1 (ru) Амиды антраниловой кислоты и их применение в качестве лекарственных средств
TNSN98025A1 (fr) Derives d'acide arylsulfonylhydroxamique, procede pour leur preparation et compositions les contenant.
EP1446136A4 (fr) Compositions curcuminoides presentant une inhibition synergique de l'expression et/ou de l'activite de la cyclooxygenase-2
TNSN98059A1 (fr) Composes inhibiteurs selectifs de cox-2, anti-inflammatoires et compositions pharmaceutiques les contenant.
AU2001272735A1 (en) Novel physiologically active peptide and use thereof
TNSN97078A1 (fr) Derives d'indole nouveaux, procede pour leur preparation et formulations pharmaceutiques les contenant
TNSN99106A1 (fr) Derives d'isothiazole nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant.
MA26420A1 (fr) Compositions pharmaceutiques mixtes pour le traitement de l'osteoporose, et procede pour leur preparation.
CA2330500A1 (fr) Compositions pharmaceutiques gelifiables
DZ3165A1 (fr) Composition alimentaire ou pharmaceutique utiliseepour prevenir ou traiter l'hyperoxalurie.
FR2442054A1 (fr) Proteines purifiees, notamment interferon, procede de preparation et compositions pharmaceutiques les contenant
FR2755136B1 (fr) Procede de preparation de nanoparticules de methylidene malonate, nanoparticules contenant eventuellement une ou plusieurs molecules biologiquement actives et compositions pharmaceutiques les contenant
TNSN01017A1 (fr) Compositions comprenant un antibiotique azalide, et procedes pour leur preparation
BR0312456A (pt) Anticorpo alterado ou fragmento funcional do mesmo, polinucleotìdeo, sequência de polinucleotìdeo, composição farmacêutica, métodos de tratamento ou profilaxia de derrame e outras doenças/distúrbios neurológicos em um ser humano, de inibição da neurodegeneração e/ou promoção da recuperação funcional e de promoção do desenvolvimento axonial, e, uso de um anticorpo anti-mag
AU558711B2 (en) Enzyme preparation for treatment of liver and kidney disease
MA27063A1 (fr) Derives d'acide acetique d'indane et leur utilisation en tant qu'agents therapeutiques, produits intermediaires, et leur methode de preparation
MA26608A1 (fr) Procede de preparation d'une composition pharmaceutique destinee au traitement de l'insuffisance cardiaque.
PL308142A1 (en) Derivatives of 2-amino-4phenyl-4-oxobutyric acids as kynureninase and/or kynurenic 3-hydroxylase inhibitors
DE60135904D1 (de) Arzneien zur behandlung von nervenerkrankungen
TNSN98124A1 (fr) Compositions de sertraline solubilisee
ATE249837T1 (de) Caspase 8-inhibitoren zur immunsuppression
TR199902564T2 (xx) K�k�rdak oligomer matris proteininin romatoid artrit tedavisinde kullan�m�.